Phase 3 Readout~month

Phase 3 Topline: An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Si

Indication
Guillain-Barre Syndrome

Other upcoming events for ANNX

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of t

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Si — ANNX Phase 3 Readout | BioSniper